The human cell line we made resistant to nemorubicin, the colocarcinoma derived HCT116, is the same human cancer cell line made resistant to trabectedin [9] for which a mutation in the XPG gene leading to premature stop codon was observed. This evidence concerns the gene ERCC5 and cancer.